Alkem实验室为287卢比购置了皮肤护理公司Adroit Biomed和矫形公司Bombay Ortho。 Alkem Laboratories acquires skincare firm Adroit Biomed and orthopedic firm Bombay Ortho for Rs 287 crore.

一家印度制药公司Alkem Laboratories通过收购一家皮肤护理公司Adroit Biomed和整形植入器制造商Bombay Ortho Industries, 正在扩大其国内存在,总价值为287卢比。 Alkem Laboratories, an Indian pharmaceutical company, is expanding its domestic presence by acquiring Adroit Biomed, a skincare company, and Bombay Ortho Industries, an orthopedic implants manufacturer, for a total of Rs 287 crore. 这些收购旨在使Alkem的投资组合多样化,并加强其在皮肤学、美容学和矫形部门的市场份额。 These acquisitions aim to diversify Alkem's portfolio and strengthen its market share in dermatology, cosmetology, and orthopedic sectors. Adroit报告了上一个财政年度的53.55卢比收入。 Adroit reported a revenue of Rs 53.55 crore in the last fiscal year. 这些交易预计将在2025年年中完成。 The deals are expected to be completed by mid-2025.